Reuters: Health
Shares of Lexicon Pharmaceuticals Inc plunged 40% on Monday after the company's appeal to the U.S. health regulator's rejection of its add-on treatment for type 1 diabetes patients was denied.
Lexicon Pharma shares plummet after FDA denies appeal against drug rejection
Lexicon Pharma shares plummet after FDA denies appeal against drug rejection
Reuters: Health
Shares of Lexicon Pharmaceuticals Inc plunged 40% on Monday after the company's appeal to the U.S. health regulator's rejection of its add-on treatment for type 1 diabetes patients was denied.
Reuters: Health
Shares of Lexicon Pharmaceuticals Inc plunged 40% on Monday after the company's appeal to the U.S. health regulator's rejection of its add-on treatment for type 1 diabetes patients was denied.
Subscribe to:
Post Comments (Atom)
Popular Posts
|
No comments:
Post a Comment